Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 2/2017

28.09.2016 | Original Paper

Changes in cardiac function and structure in newly diagnosed Graves’ disease. A conventional and 2D-speckle tracking echocardiography study

verfasst von: K. Aroditis, M. Pikilidou, E. Vourvouri, L. Hadjistavri, P. Zebekakis, J. Yovos, G. Efthimiadis, H. Karvounis

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Overproduction of thyroid hormones leads to structural as well as functional cardiac changes. Conventional echocardiography but also recently developed sophisticated two-dimensional echocardiography speckle (2D-STE) tracking allow elaborate evaluation of these changes. Our purpose was to investigate the effects of thyroid hormones overproduction on the heart in patients with Graves’ disease and changes that occur after 6 months thyrostatic therapy. We conducted a prospective, case-control study of 6 months duration. Full echocardiographic assessment at diagnosis and after 6 months of thyrostatic therapy were performed in 44 patients with Graves’ disease, aged 37.6 ± 9.1 years. Additionally, 43 euthyroid controls were studied for the same time period. Left ventricular end diastolic diameter (LVEDD) and left ventricular end systolic diameter (LVESD) were higher in the patient group while triscupid annular plane systolic excursion (TAPSE) was lower in the patient group. Moreover, left ventricular (LV) mass index and left atrium (LA) volume index were higher in the Graves’ disease group. Diastolic impairment as assessed with conventional echocardiography including tissue Doppler was present in the patient group (E/A ratio 0.87 ± 0.10,). 2D-STE analysis, revealed an increase in the strain rate at the isovolumic relaxation time (SRIVRT, 0.310 ± 0.07 patients versus 0.298 ± 0.09 s−1 controls). Improvement in diastolic and right systolic function as well as in left ventricular structural parameters was observed after restoration of euthyroidism (E/A ratio from 0.87 ± 0.10 versus 0.9 ± 0.08, p < 0.05). Patients with newly diagnosed Graves’ showed an improvement in diastolic function, right systolic function and structural parameters after 6 months of thyrostatic treatment.
Literatur
2.
Zurück zum Zitat Pearce EN, Yang Q, Benjamin EJ, Aragam J, Vasan RS (2010) Thyroid function and left ventricular structure and function in the Framingham Heart Study. Thyroid 20:369–373CrossRefPubMedPubMedCentral Pearce EN, Yang Q, Benjamin EJ, Aragam J, Vasan RS (2010) Thyroid function and left ventricular structure and function in the Framingham Heart Study. Thyroid 20:369–373CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Dillmann W (2010) Cardiac hypertrophy and thyroid hormone signaling. Heart Fail Rev 15:125–132CrossRefPubMed Dillmann W (2010) Cardiac hypertrophy and thyroid hormone signaling. Heart Fail Rev 15:125–132CrossRefPubMed
4.
Zurück zum Zitat Klein I, Ojamaa K (2001) Thyroid hormone: targeting the vascular smooth muscle cell. Circ Res 88:260–261CrossRefPubMed Klein I, Ojamaa K (2001) Thyroid hormone: targeting the vascular smooth muscle cell. Circ Res 88:260–261CrossRefPubMed
5.
Zurück zum Zitat Mondillo S, Galderisi M, Mele D et al (2011) Speckle-tracking echocardiography: a new technique for assessing myocardial function. J Ultrasound Med 30:71–83CrossRefPubMed Mondillo S, Galderisi M, Mele D et al (2011) Speckle-tracking echocardiography: a new technique for assessing myocardial function. J Ultrasound Med 30:71–83CrossRefPubMed
6.
Zurück zum Zitat Dorr M, Ittermann T, Aumann N et al (2010) Subclinical hyperthyroidism is not associated with progression of cardiac mass and development of left ventricular hypertrophy in middle-aged and older subjects: results from a 5-year follow-up. Clin Endocrinol (Oxf) 73:821–826CrossRef Dorr M, Ittermann T, Aumann N et al (2010) Subclinical hyperthyroidism is not associated with progression of cardiac mass and development of left ventricular hypertrophy in middle-aged and older subjects: results from a 5-year follow-up. Clin Endocrinol (Oxf) 73:821–826CrossRef
7.
Zurück zum Zitat Iqbal A, Schirmer H, Lunde P et al (2007) Thyroid stimulating hormone and left ventricular function. J Clin Endocrinol Metab 92:3504–3510CrossRefPubMed Iqbal A, Schirmer H, Lunde P et al (2007) Thyroid stimulating hormone and left ventricular function. J Clin Endocrinol Metab 92:3504–3510CrossRefPubMed
8.
Zurück zum Zitat Kaminski G, Michalkiewicz D, Makowski K et al (2011) Prospective echocardiographic evaluation of patients with endogenous subclinical hyperthyroidism and after restoring euthyroidism. Clin Endocrinol (Oxf) 74:501–507CrossRef Kaminski G, Michalkiewicz D, Makowski K et al (2011) Prospective echocardiographic evaluation of patients with endogenous subclinical hyperthyroidism and after restoring euthyroidism. Clin Endocrinol (Oxf) 74:501–507CrossRef
9.
Zurück zum Zitat Smit JW, Eustatia-Rutten CF, Corssmit EP et al (2005) Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. J Clin Endocrinol Metab 90:6041–6047CrossRefPubMed Smit JW, Eustatia-Rutten CF, Corssmit EP et al (2005) Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. J Clin Endocrinol Metab 90:6041–6047CrossRefPubMed
10.
Zurück zum Zitat Abdulrahman RM, Delgado V, Hoftijzer HC et al (2011) Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma. Thyroid 21:471–476CrossRefPubMed Abdulrahman RM, Delgado V, Hoftijzer HC et al (2011) Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma. Thyroid 21:471–476CrossRefPubMed
11.
Zurück zum Zitat Biondi B (2012) Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur J Endocrinol 167:609–618CrossRefPubMed Biondi B (2012) Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur J Endocrinol 167:609–618CrossRefPubMed
12.
Zurück zum Zitat Hadzovic-Dzuvo A, Kucukalic-Selimovic E, Nakas-Icindic E et al (2010) Echocardiographic evaluation of cardiac function in female patients with thyroid disorders. Bosn J Basic Med Sci 10:112–115PubMed Hadzovic-Dzuvo A, Kucukalic-Selimovic E, Nakas-Icindic E et al (2010) Echocardiographic evaluation of cardiac function in female patients with thyroid disorders. Bosn J Basic Med Sci 10:112–115PubMed
13.
Zurück zum Zitat Mintz G, Pizzarello R, Klein I (1991) Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. J Clin Endocrinol Metab 73:146–150CrossRefPubMed Mintz G, Pizzarello R, Klein I (1991) Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. J Clin Endocrinol Metab 73:146–150CrossRefPubMed
14.
Zurück zum Zitat Roef GL, Rietzschel ER, Van Daele CM et al (2014) Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects. Thyroid 24:223–231CrossRefPubMedPubMedCentral Roef GL, Rietzschel ER, Van Daele CM et al (2014) Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects. Thyroid 24:223–231CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270CrossRefPubMed Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270CrossRefPubMed
16.
Zurück zum Zitat Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613–618CrossRefPubMed Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613–618CrossRefPubMed
17.
Zurück zum Zitat Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23:685–713CrossRefPubMed Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23:685–713CrossRefPubMed
18.
Zurück zum Zitat Harun S (2006) The correlation between free thyroxine levels and left ventricular mass in Graves’ disease. Acta Med Indones 38:193–195PubMed Harun S (2006) The correlation between free thyroxine levels and left ventricular mass in Graves’ disease. Acta Med Indones 38:193–195PubMed
19.
Zurück zum Zitat Yingchoncharoen T, Agarwal S, Popovic ZB, Marwick TH (2013) Normal ranges of left ventricular strain: a meta-analysis. J Am Soc Echocardiogr 26:185–191CrossRefPubMed Yingchoncharoen T, Agarwal S, Popovic ZB, Marwick TH (2013) Normal ranges of left ventricular strain: a meta-analysis. J Am Soc Echocardiogr 26:185–191CrossRefPubMed
20.
Zurück zum Zitat Sokmen A, Acar G, Sokmen G et al (2013) Evaluation of atrial electromechanical delay and diastolic functions in patients with hyperthyroidism. Echocardiography 30:1194–1201CrossRefPubMed Sokmen A, Acar G, Sokmen G et al (2013) Evaluation of atrial electromechanical delay and diastolic functions in patients with hyperthyroidism. Echocardiography 30:1194–1201CrossRefPubMed
21.
Zurück zum Zitat Yue WS, Chong BH, Zhang XH et al (2011) Hyperthyroidism-induced left ventricular diastolic dysfunction: implication in hyperthyroidism-related heart failure. Clin Endocrinol (Oxf) 74:636–643CrossRef Yue WS, Chong BH, Zhang XH et al (2011) Hyperthyroidism-induced left ventricular diastolic dysfunction: implication in hyperthyroidism-related heart failure. Clin Endocrinol (Oxf) 74:636–643CrossRef
22.
Zurück zum Zitat Petretta M, Bonaduce D, Spinelli L et al (2001) Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur J Endocrinol 145:691–696CrossRefPubMed Petretta M, Bonaduce D, Spinelli L et al (2001) Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur J Endocrinol 145:691–696CrossRefPubMed
23.
Zurück zum Zitat Tsymbaliuk I, Unukovych D, Shvets N, Dinets A (2015) Cardiovascular complications secondary to graves’ disease: a prospective study from ukraine. PLoS One 10:e0122388CrossRefPubMedPubMedCentral Tsymbaliuk I, Unukovych D, Shvets N, Dinets A (2015) Cardiovascular complications secondary to graves’ disease: a prospective study from ukraine. PLoS One 10:e0122388CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Oliveros-Ruiz L, Vallejo M, Diez Canseco LF, Cardenas M, Hermosillo JA.(2013) Determinants of thyrotoxic cardiomyopathy recovery. Biomed Res Int 2013:452709CrossRefPubMedPubMedCentral Oliveros-Ruiz L, Vallejo M, Diez Canseco LF, Cardenas M, Hermosillo JA.(2013) Determinants of thyrotoxic cardiomyopathy recovery. Biomed Res Int 2013:452709CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Berlin T, Lubina A, Levy Y, Shoenfeld Y (2006) Graves’ disease presenting as right heart failure. Isr Med Assoc J 8:217–218PubMed Berlin T, Lubina A, Levy Y, Shoenfeld Y (2006) Graves’ disease presenting as right heart failure. Isr Med Assoc J 8:217–218PubMed
26.
Zurück zum Zitat Marcisz C, Jonderko G, Wroblewski T, Kurzawska G, Mazur F (2006) Left ventricular mass in patients with hyperthyroidism. Med Sci Monit 12:CR481–CR486PubMed Marcisz C, Jonderko G, Wroblewski T, Kurzawska G, Mazur F (2006) Left ventricular mass in patients with hyperthyroidism. Med Sci Monit 12:CR481–CR486PubMed
28.
Zurück zum Zitat Nixon JV, Anderson RJ, Cohen ML (1979) Alterations in left ventricular mass and performance in patients treated effectively for thyrotoxicosis. A comparative echocardiographic study. Am J Med 67:268–276CrossRefPubMed Nixon JV, Anderson RJ, Cohen ML (1979) Alterations in left ventricular mass and performance in patients treated effectively for thyrotoxicosis. A comparative echocardiographic study. Am J Med 67:268–276CrossRefPubMed
Metadaten
Titel
Changes in cardiac function and structure in newly diagnosed Graves’ disease. A conventional and 2D-speckle tracking echocardiography study
verfasst von
K. Aroditis
M. Pikilidou
E. Vourvouri
L. Hadjistavri
P. Zebekakis
J. Yovos
G. Efthimiadis
H. Karvounis
Publikationsdatum
28.09.2016
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 2/2017
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-016-0984-z

Weitere Artikel der Ausgabe 2/2017

The International Journal of Cardiovascular Imaging 2/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.